Dr. Vishnu Vardhan Reddy Naravadi, MD

Dr. Naravadi practices at Charleston Area Medical Center General Hospital in Charleston, West Virginia.

Dr. Naravadi's NPI, 1760611776, was assigned on July 11, 2009. Dr. Naravadi holds West Virginia license 29606.

Dr. Naravadi's primary practice is Charleston Area Medical Center General Hospital, at 501 Morris St, Charleston, WV 25301 in Kanawha County. The practice phone is (304) 388-3939.

Dr. Naravadi's primary practice is Charleston Area Medical Center General Hospital in Charleston, West Virginia. Dr. Naravadi is also affiliated with MUSC Health Lancaster Medical Center. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Naravadi to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naravadi practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Naravadi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Naravadi's licenses on file in 2 states: West Virginia and Illinois.

CMS data shows 1,139 Medicare services from Dr. Naravadi across 19 procedure codes in 2024, for 585 Medicare patients. Medicare paid $121,898 for them.

CMS counts 585 Medicare patients who saw Dr. Naravadi in 2024. The largest group is 65 to 74, with 302 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Naravadi's median patient age at 60, with 58% women.

In 2024, Dr. Naravadi wrote 357 Medicare Part D claims for 163 patients. 80% of them were for generic drugs. CMS names the drug for 291 of them, across 7 drugs with 11 or more claims each, at $21,870 in total drug cost. In 2023, CMS named 212 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Naravadi for performance year 2024, reported as part of a group. Dr. Naravadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 239 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Naravadi, more than 93% of the clinicians it reports for that procedure.

CMS Open Payments shows 44 general payments to Dr. Naravadi from 15 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 97% of the total. Pfizer Inc. paid the most, $216.